Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insulin resistance and beta 3-adrenergic receptor function].

I Kobayashi1, T Ishigami, S Umemura

  • 1Second Department of Internal Medicine, Yokohama City University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The usefulness of high dose etoposide for peripheral blood stem cell harvest].

Nihon Sanka Fujinka Gakkai zasshi·1996
Same author

Effect of high sucrose feeding on fat accumulation in the male Wistar rat.

Obesity research·1996
Same author

Complications of childhood Sjögren syndrome.

European journal of pediatrics·1996
Same author

Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.

Diabetes care·1996
Same author

Human cerebral activity with increasing inspiratory force: a study using positron emission tomography.

Journal of applied physiology (Bethesda, Md. : 1985)·1996
Same author

Interferon-alpha potentiates the antiproliferative activity of CPT-11 against human colon cancer xenografts in nude mice.

Anticancer research·1996
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Beta 3-adrenergic receptors regulate fat breakdown and energy expenditure. A specific gene mutation is linked to obesity and type 2 diabetes, though its precise role in insulin resistance requires further investigation.

Area of Science:

  • Adrenergic Receptor Signaling
  • Metabolic Regulation
  • Obesity and Diabetes Research

Context:

  • Beta 3-adrenergic receptors (ADRB3) are primarily found on white and brown adipocytes.
  • ADRB3 activation promotes lipolysis and thermogenesis, influencing energy expenditure.
  • ADRB3 dysfunction is hypothesized to contribute to obesity and insulin resistance.

Purpose:

  • To explore the association between beta 3-adrenergic receptor function and metabolic disorders.
  • To investigate the prevalence and implications of the Trp64Arg ADRB3 gene mutation.
  • To clarify the detailed role of ADRB3 in the development of insulin resistance.

Summary:

  • The Trp64Arg mutation in the beta 3-adrenergic receptor gene is common in certain populations and linked to obesity and early-onset type 2 diabetes.

Related Experiment Videos

  • Despite minimal acute functional impact, this mutation's association with metabolic diseases warrants further study.
  • The precise mechanisms by which beta 3-adrenergic receptors influence insulin resistance remain incompletely understood.

    • Impact:

    • Understanding ADRB3's role could reveal novel therapeutic targets for obesity and type 2 diabetes.
    • Genetic screening for ADRB3 mutations may aid in identifying individuals at higher risk.
    • Further research is crucial for translating these findings into clinical applications for metabolic disease management.